{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-22-000045","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.750455+00:00","generated_at":"2026-06-24T03:03:32.152811+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"medium","headline":"Haemonetics names CFO James D'Arecca as principal accounting officer following controller's departure","bullets":["James C. D'Arecca, EVP/CFO, assumes principal accounting officer role effective Aug 5, 2022, replacing departing controller Dan Goldstein.","2022 annual meeting held Aug 5 with 94.1% quorum; all nine director nominees elected with majority support.","Shareholders approved say-on-pay (43.98M for, 2.71M against) and ratified Ernst & Young as auditor (47.09M for, 1.16M against).","Vote totals show high approval for most directors; Charles Dockendorff and Ellen Zane received the most withhold votes at 5.96M and 3.27M, respectively."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-22-000045","json":"https://secwatch.observer/filing/0000313143-22-000045.json","markdown":"https://secwatch.observer/filing/0000313143-22-000045.md","text":"https://secwatch.observer/filing/0000313143-22-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/0000313143-22-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/hae-20220805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:03:32.152811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06d2008b4a","claim":"James C. D'Arecca was appointed as principal accounting officer at HAEMONETICS CORP.","evidence_excerpt":"On August 5, 2022, the Board of Directors of Haemonetics Corporation (the “Company”) appointed James C. D’Arecca, Executive Vice President, Chief Financial Officer, as the Company’s principal accounting officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/0000313143-22-000045-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}